# Antimicrobial resistance in ESKAPEE pathogens isolated from institutionalized vs. non-institutionalized elderly patients with urinary tract infections: a 5-years study

**Authors:** Guillermo Ramírez-Vilariño, Iker Alonso-González, Amanda Lopez-Picado, Natalia Burgos-Alonso

PMC · DOI: 10.1007/s00345-026-06333-0 · World Journal of Urology · 2026-03-13

## TL;DR

This study found that elderly patients in nursing homes have higher rates of antibiotic-resistant infections compared to those living outside institutions.

## Contribution

The study provides a 5-year analysis of antimicrobial resistance in ESKAPEE pathogens among institutionalized elderly patients.

## Key findings

- Institutionalized patients showed significantly higher antimicrobial resistance rates to fluoroquinolones and MRSA.
- Nursing homes had increased multidrug-resistant strains of Escherichia coli and Klebsiella pneumoniae.
- Escherichia coli was the most frequently isolated ESKAPEE pathogen in the study.

## Abstract

Urinary tract infections are frequently diagnosed in institutionalized patients, often resulting in unnecessary antibiotic use, especially in asymptomatic cases. This, along with prevalent asymptomatic bacteriuria in the elderly, contributes to antimicrobial resistance, with nursing homes serving as key reservoirs.

This study aims to delineate the burden of AMR in ESKAPEE uro-pathogens among elderly patients (aged ≥ 65 years) and to assess the impact of institutionalization on AMR rates, in accordance with EUCAST guidelines.

A retrospective observational study was carried out between 2016 and 2020 using urine culture data obtained from the Microbiology Department of Hospital San Pedro (Spain). Positive urine cultures were reviewed, and isolates belonging to the ESKAPEE group of pathogens were identified and analyzed anonymously.

A total of 34,791 urine cultures were analyzed, of which 26,127 (75.1%) were from the ESKAPEE group. Escherichia coli was identified as the most frequently isolated ESKAPEE pathogen (80.5%). Institutionalized patients showed significantly higher AMR rates for numerous antibiotics compared to their non-institutionalized counterparts, particularly manifest in the pronounced resistance rates to fluoroquinolones and a greater prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in nursing homes (p<0.001). Additionally, NH settings demonstrated increased rates of multidrug-resistant (MDR) strains of Escherichia coli and Klebsiella pneumoniae, underscoring a critical challenge in managing UTIs in these environments.

In anticipation of a potential post-antibiotic era, it is imperative to enhance infection control measures and antibiotic stewardship in nursing homes to address the growing burden of MDR bacteria and safeguard patient health.

## Linked entities

- **Species:** Escherichia coli (taxon 562), Klebsiella pneumoniae (taxon 573)

## Full-text entities

- **Diseases:** hypotension (MESH:D007022), death (MESH:D003643), delirium (MESH:D003693), malaria (MESH:D008288), infection (MESH:D007239), HIV (MESH:D015658), respiratory infections (MESH:D012141), UTIs (MESH:D014552), prostatitis (MESH:D011472), bacteriuria (MESH:D001437), gram-negative infection (MESH:D016905), AMR (MESH:D060467), tachycardia (MESH:D013610), XDR (MESH:D054908), MDR (MESH:D018088), cystitis (MESH:D003556), MRSA (MESH:D013203), ESKAPEE bacteria (MESH:C000719206), urinary incontinence (MESH:D014549), immune dysfunction (MESH:D007154)
- **Chemicals:** piperacil-lin-tazobactam (MESH:D000077725), aminoglycoside (MESH:D000617), imipenem (MESH:D015378), daptomycin (MESH:D017576), penicillin (MESH:D010406), van-comycin (MESH:D014640), Fluoroquinolones (MESH:D024841), teicoplanin (MESH:D017334), erythromycin (MESH:D004917), methicillin (MESH:D008712), IPM (-), mero-penem (MESH:D000077731), cephalosporins (MESH:D002511), PEN (MESH:C058388), norfloxacin (MESH:D009643), ertapenem (MESH:D000077727), clindamycin (MESH:D002981), ciprofloxacin (MESH:D002939), amikacin (MESH:D000583), DAP (MESH:C041756), linezolid (MESH:D000069349), cefuroxime (MESH:D002444), levofloxacin (MESH:D064704), carbapenems (MESH:D015780), beta-lactam (MESH:D047090), gentamicin (MESH:D005839), ceftolozane-tazobactam (MESH:C000594038), Fosfomycin (MESH:D005578), sulfamethoxazole-trimethoprim (MESH:D015662), oxacillin (MESH:D010068), CAZ (MESH:D002442), ni-trofurantoin (MESH:D009582), amoxicillin-clavulanate (MESH:D019980), ETP (MESH:D005000), trimethoprim (MESH:D014295), tetracycline (MESH:D013752), tobramycin (MESH:D014031), CFX (MESH:D002440), cefotaxime (MESH:D002439)
- **Species:** Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Enterobacter (genus) [taxon 547], Acinetobacter baumannii (species) [taxon 470], Staphylococcus aureus (species) [taxon 1280], Pseudomonas aeruginosa (species) [taxon 287], Oryza sativa (Asian cultivated rice, species) [taxon 4530], Enterobacteriaceae (enterobacteria, family) [taxon 543], Streptococcus pneumoniae (species) [taxon 1313], Enterococcus faecium (species) [taxon 1352], Escherichia coli (E. coli, species) [taxon 562], Klebsiella pneumoniae (species) [taxon 573], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12987801/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12987801/full.md

---
Source: https://tomesphere.com/paper/PMC12987801